You forget that Europe has twice as many diabetics as the...

You forget that Europe has twice as many diabetics as the states, if they can break into that market and sell a similar number of tests there, as they hopefully will do in America, their income should surely be well over a hundred million Aussie per year. Diabetes is a global problem that is only going to get worse, so this test imo will need to be administered far more commonly than investors realize.

I am very surprised there is not more thirst from investors on this one because once this test is up and running, Proteomics will be a very profitable company, one which should be able to pay a decent dividend fairly quickly. Not to mention they have other tests, which will also be positive for their bottom line going forward. That's why I know, with the holdings I have, I'll be looking at a very comfortable retirement within the next few years. Patience will be rewarded with this one.